Thursday bearish breakdown suggested that short-term overbought correction off the March high of 1883 on the S&P 500 index had evolved into an...(read more
Shares of Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) are currently up 7% at $7.96 per share during Wednesday afternoon trading. Today's trading range for shares of Vanda Pharmaceuticals Inc has been between $7.50 and $8.00 per share. The...(read more
Hapoalim Securities is out with a research report this morning, where it reiterates its Buy rating on Vanda Pharmaceuticals (NASDAQ: VNDA); it has a $15.00 price target on the stock.
The HS analysts noted that Fanapt is catching up...(read more